These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 33147750)

  • 21. Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics.
    Senkevich K; Gan-Or Z
    Parkinsonism Relat Disord; 2020 Apr; 73():60-71. PubMed ID: 31761667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau accumulation in degradative organelles is associated to lysosomal stress.
    Piovesana E; Magrin C; Ciccaldo M; Sola M; Bellotto M; Molinari M; Papin S; Paganetti P
    Sci Rep; 2023 Oct; 13(1):18024. PubMed ID: 37865674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal function.
    Arotcarena ML; Soria FN; Cunha A; Doudnikoff E; Prévot G; Daniel J; Blanchard-Desce M; Barthélémy P; Bezard E; Crauste-Manciet S; Dehay B
    Aging Cell; 2022 Apr; 21(4):e13584. PubMed ID: 35318803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease.
    Matrone C; Dzamko N; Madsen P; Nyegaard M; Pohlmann R; Søndergaard RV; Lassen LB; Andresen TL; Halliday GM; Jensen PH; Nielsen MS
    PLoS One; 2016; 11(8):e0160501. PubMed ID: 27509067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.
    Wei J; Takamatsu Y; Wada R; Fujita M; Ho G; Masliah E; Hashimoto M
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of high cholesterol in a Parkinson's disease model: Prevention of lysosomal leakage versus stimulation of α-synuclein aggregation.
    Eriksson I; Nath S; Bornefall P; Giraldo AM; Öllinger K
    Eur J Cell Biol; 2017 Mar; 96(2):99-109. PubMed ID: 28109635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
    Martin S; Smolders S; Van den Haute C; Heeman B; van Veen S; Crosiers D; Beletchi I; Verstraeten A; Gossye H; Gelders G; Pals P; Hamouda NN; Engelborghs S; Martin JJ; Eggermont J; De Deyn PP; Cras P; Baekelandt V; Vangheluwe P; Van Broeckhoven C;
    Acta Neuropathol; 2020 Jun; 139(6):1001-1024. PubMed ID: 32172343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.
    Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM
    Mov Disord; 2015 Oct; 30(12):1639-47. PubMed ID: 25594542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease.
    Date Y; Sasazawa Y; Kitagawa M; Gejima K; Suzuki A; Saya H; Kida Y; Imoto M; Itakura E; Hattori N; Saiki S
    Elife; 2024 Jul; 13():. PubMed ID: 38899618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of the autophagy-lysosomal system in appendix in Parkinson's disease.
    Gordevicius J; Li P; Marshall LL; Killinger BA; Lang S; Ensink E; Kuhn NC; Cui W; Maroof N; Lauria R; Rueb C; Siebourg-Polster J; Maliver P; Lamp J; Vega I; Manfredsson FP; Britschgi M; Labrie V
    Nat Commun; 2021 Aug; 12(1):5134. PubMed ID: 34446734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired Autophagic-Lysosomal Fusion in Parkinson's Patient Midbrain Neurons Occurs through Loss of ykt6 and Is Rescued by Farnesyltransferase Inhibition.
    Pitcairn C; Murata N; Zalon AJ; Stojkovska I; Mazzulli JR
    J Neurosci; 2023 Apr; 43(14):2615-2629. PubMed ID: 36788031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysosome-dependent pathways as a unifying theme in Parkinson's disease.
    Tofaris GK
    Mov Disord; 2012 Sep; 27(11):1364-9. PubMed ID: 22927213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.
    Moors T; Paciotti S; Chiasserini D; Calabresi P; Parnetti L; Beccari T; van de Berg WD
    Mov Disord; 2016 Jun; 31(6):791-801. PubMed ID: 26923732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
    Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
    Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A lysosomal lair for a pathogenic protein pair.
    Dawson TM; Dawson VL
    Sci Transl Med; 2011 Jul; 3(91):91ps28. PubMed ID: 21753118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.
    Parekh P; Sharma N; Gadepalli A; Shahane A; Sharma M; Khairnar A
    ACS Chem Neurosci; 2019 Sep; 10(9):3914-3926. PubMed ID: 31385687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Possible Involvement of Genes Related to Lysosomal Storage Disorders in the Pathogenesis of Parkinson's Disease].
    Rudenok MM; Alieva AK; Nikolaev MA; Kolacheva AA; Ugryumov MV; Pchelina SN; Slominsky PA; Shadrina MI
    Mol Biol (Mosk); 2019; 53(1):28-36. PubMed ID: 30895950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
    Huebecker M; Moloney EB; van der Spoel AC; Priestman DA; Isacson O; Hallett PJ; Platt FM
    Mol Neurodegener; 2019 Nov; 14(1):40. PubMed ID: 31703585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagy in Parkinson's Disease.
    Nechushtai L; Frenkel D; Pinkas-Kramarski R
    Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.